Catalyst Wire Dossier Catalyst Wire Dossier

Naltrexone/Bupropion (Contrave)

Naltrexone; Bupropion · Orexigen Therapeutics
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Naltrexone/Bupropion (Contrave), covering 2017-02-27 to 2017-02-27. Get the full timeline:

Most recent: Clinical Trial Update: Naltrexone/Bupropion Cardiovascular Outcomes Study [Phase 4]

See pricing